0 (0%)		10-15 12:13
Open: High: Volume: 0		Pre. Close: Low: Market Cap: 0(M)

Short term
Mid term
Targets	6-month :	11.7	1-year :	13.66
Resists	First :	10.02	Second :	11.7
Pivot price	9.85
Supports	First :	9.82	Second :	9.71
MAs	MA(5) :	9.83	MA(20) :	9.87
	MA(100) :	9.87	MA(250) :	9.67
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	37	D(3) :	31.9
RSI	RSI(14): 50.4
52-week	High :	10.11	Low :	8.43

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ IGA ] has closed below upper band by 40.8%. Bollinger Bands are 16.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	9.84 - 9.88	9.88 - 9.92
Low:	9.65 - 9.69	9.69 - 9.73
Close:	9.75 - 9.82	9.82 - 9.9

Wed, 15 Oct 2025
IgA Nephropathy Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | Visterra, Chinook Therapeutics, Novartis, IgA proteases Selecta Biosciences - Barchart.com

Wed, 15 Oct 2025
Bitcoin Depot partners with IGA to bring bitcoin ATMs to grocery stores - ATM Marketplace

Wed, 15 Oct 2025
Hansen's IGA Markets may take over Molter's Fresh Market in Tomah - La Crosse Tribune

Wed, 15 Oct 2025
Bitcoin Depot and IGA team up to bring Bitcoin access to neighborhood grocery stores - Mass Market Retailers

Wed, 15 Oct 2025
Efficacy and safety of hydroxychloroquine in IgA nephropathy with nasopharyngeal or intestinal mucosal and non-mucosal infections - BMC Nephrology

Wed, 15 Oct 2025
KDIGO’s New IgA Nephropathy Guideline Is Paradigm-Shifting - Renal and Urology News

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange:
Sector:
Industry:
Shares Out	15 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	33.1 (%)
Shares Short	23 (K)
Shares Short P.Month	16 (K)

EPS	1.5
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	10.44
Profit Margin	474 %
Operating Margin	62.3 %
Return on Assets (ttm)	1.2 %
Return on Equity (ttm)	14.6 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0.31
Sales Per Share	0.31
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	6.53
PEG Ratio	0
Price to Book value	0.94
Price to Sales	31.16
Price to Cash Flow	0

Dividend	0.09
Forward Dividend	0
Dividend Yield	0.9%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.